Javier Cortes

81PUBLICATIONS
464CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Jul 31, 2026
TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10.

|Jul 09, 2026
Modulation of the response to immunotherapy in triple-negative breast cancer: the role of the microbiota and microbial metabolites in the tumor microenvironment.

|May 19, 2026
Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial.

|Feb 03, 2026
PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

Rosie A B Voorthuis, Mafalda Oliveira, Annelot G J van Rossum

|Jan 30, 2026
Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy.

Giulia Notini, Giampaolo Bianchini, José Manuel Pérez-García

|Dec 03, 2025
Palbociclib, Trastuzumab, and Endocrine Therapy in Pretreated HER2-Positive and PAM50 Luminal Advanced Breast Cancer: Randomized Phase II, SOLTI-1303 PATRICIA Trial.

Eva Ciruelos, Tomás Pascual, Guillermo Villacampa

Pageof 14

Frequent Collaborators

13 joint publications

Hope S Rugo

10 joint publications

Aditya Bardia

10 joint publications

Giuseppe Curigliano

9 joint publications

Mafalda Oliveira